Furthermore, analysis of GSE95414 comparing HER2+, T-DM1 sensitive, gastric cancer, NCI-N87 cells to their TDM1R counterparts indicated potential gains in the expression of FGFR2, 3, and 4 (Supplementary Fig. S3A). The gene discussed is ERBB2; the disease is gastric cancer.